Investors Invited to Lead Class Action Against Capricor Therapeutics Over Alleged Fraud

Capricor Therapeutics Investors' Opportunity to Take Action

In a significant development for shareholders of Capricor Therapeutics, Inc. (CAPR), a prominent law firm, the Law Offices of Howard G. Smith, has reached out to investors who have incurred substantial losses related to the company's recent activities. This outreach comes with an opportunity for these investors to step forward and potentially lead a class action lawsuit centered on allegations of securities fraud. Investors affected by the company's purported misconduct are encouraged to act promptly, as the deadline for participation in this ongoing lawsuit is approaching soon on September 28, 2026.

Allegations Against Capricor Therapeutics

The lawsuit is focusing on the period between December 17, 2025, and July 26, 2026, during which it's claimed that the company and its executives issued materially false and misleading statements while failing to disclose critical adverse facts about their operations and prospects. Key issues highlighted in the allegations include:
1. The alleged alterations made to the pre-specified statistical analysis plan for clinical data regarding the company’s lead product, Deramiocel.
2. Failure to disclose that these changes had not been vetted or approved by the FDA prior to the resubmission of Deramiocel’s Biologics License Application (BLA).
3. The potential risk associated with the FDA rejecting the clinical results, which could indicate insufficient evidence of Deramiocel's effectiveness.
4. A significant risk posed to the regulatory approval process concerning Deramiocel, aimed at treating Duchenne muscular dystrophy.
5. The misleading assertions regarding the company's business health and operational chances due to the aforementioned issues.

As these developments unfold, Capricor Therapeutics investors are urged to carefully assess their legal options and take necessary actions to safeguard their interests.

Taking Action

The Law Offices of Howard G. Smith outlines the necessary steps for investors wishing to join the class action. Those who believe they have experienced financial losses due to the alleged fraudulent activities are encouraged to contact the firm, either via email at [email protected] or by telephone at (215) 638-4847. Additionally, potential participants can visit the firm's website for more information and further assistance.

It's important to note that while this initial contact is crucial, investors do not need to take any immediate action to be part of the class action; retaining legal counsel is optional, and they can remain absent members if they choose.

As the legal landscape surrounding this case continues to develop, those impacted by the situation are urged to stay informed and proactive in protecting their investments. The unfolding lawsuit not only represents a chance for financial recuperation but also serves as a reminder of the importance of transparency and truthfulness in corporate communications.

For further details or to engage with this opportunity, reach out to the Law Offices of Howard G. Smith, and ensure your voice and interests within this critical legal proceeding are heard.